dr. snyder discusses emerging agents in myelofibrosis
Published 6 years ago • 126 plays • Length 1:19Download video MP4
Download video MP3
Similar videos
-
1:46
dr. snyder on ruxolitinib in patients with myelofibrosis
-
1:51
dr. snyder on transplant updates in myelofibrosis
-
0:50
dr. snyder on how ruxolitinib and fedratinib may pave the way to transplant in myelofibrosis
-
4:58
treatment of myelofibrosis: emerging therapies
-
2:18
dr. snyder on the quest to revolutionize management of myelofibrosis
-
2:22
dr. scherber discusses ruxolitinib failure in myelofibrosis
-
2:26
dr. dunavin on treatment considerations in myelofibrosis
-
0:49
dr. gerds on addressing anemia in myelofibrosis
-
1:19
dr. gerds on luspatercept to treat anemia in myelofibrosis
-
1:10
dr. bradley on the utility of ruxolitinib in myelofibrosis and polycythemia vera
-
1:47
dr. oh on the development of jak inhibitors in myelofibrosis
-
1:25
dr. bose on the utility of ruxolitinib in myelofibrosis
-
14:05
myelofibrosis: emerging jak2 inhibitor combination treatment strategies
-
1:02
dr. kremyanskaya on unmet needs in myelofibrosis
-
38:10
a treatment option in myelofibrosis
-
0:59
dr. michaelis on fedratinib in myelofibrosis treatment
-
1:27
dr. kuykendall on choosing ruxolitinib or fedratinib in myelofibrosis
-
25:39
for myelofibrosis patients: latest on treatments from top doctor | dr. srdan verstovsek, md anderson
-
1:12
dr. mesa on the differences between fedratinib and ruxolitinib in myelofibrosis